Advertisement

Role of Alcohol and Metabolic Diseases in Colorectal Carcinogenesis

  • Tetsuji TakayamaEmail author
  • Yasushi Sato
  • Naoki Muguruma
Chapter

Abstract

Alcohol consumption was significantly associated with a risk of colorectal cancer with a relative risk ranging from 1.10 to 1.44 depending on the amount of intake. However, light intake of alcohol was not associated with incidence of colorectal cancer. Metabolic syndrome was also significantly associated with a risk of colorectal cancer with a relative risk ranging from 1.25 to 1.41. Of the four components of metabolic syndrome, dysglycemia and obesity were particularly associated with colorectal cancer risk. High levels of serum triglyceride were associated with increased colorectal cancer risk. However, there was no apparent association between raised blood pressure and colorectal cancer risk.

Keywords

Alcohol Metabolic syndrome Colorectal cancer Relative risk Dysglycemia Obesity 

References

  1. 1.
    World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington: American Institute for Cancer Research; 2007.Google Scholar
  2. 2.
    IARC Working Group. IARC monographs on the evaluation of carcinogenic risk to humans: alcohol consumption and ethylcalbamate, vol. 96. Lyon: International Agency of Research on Cancer; 2010.Google Scholar
  3. 3.
    Vieira AR, Abar L, Chan DSM, Vingeliene S, et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR continuous update project. Ann Oncol. 2017;28(8):1788–802.CrossRefGoogle Scholar
  4. 4.
    Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br J Cancer. 2015;112:580–93.CrossRefGoogle Scholar
  5. 5.
    Choi YJ, Myung SK, Lee JH. Light alcohol drinking and risk of cancer: a meta-analysis of cohort studies. Cancer Res Treat. 2018;50(2):474–87.CrossRefGoogle Scholar
  6. 6.
    Snover DC, Ahnen DJ, Burt RW. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: IARC; 2010. p. 160–5.Google Scholar
  7. 7.
    Zhu JZ, Wang YM, Zhou QY, et al. Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma. Aliment Pharmacol Ther. 2014;40(4):325–37.CrossRefGoogle Scholar
  8. 8.
    Ben Q, Wang L, Liu J, et al. Alcohol drinking and the risk of colorectal adenoma: a dose-response meta-analysis. Eur J Cancer Prev. 2015;24(4):286–95.CrossRefGoogle Scholar
  9. 9.
    Bailie L, Loughrey MB, Coleman HG. Lifestyle risk factors for serrated colorectal polyps: a systematic review and meta-analysis. Gastroenterology. 2017;152(1):92–104.CrossRefGoogle Scholar
  10. 10.
    Kennedy DA, Stern SJ, Moretti M, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2011;35(1):2–10.CrossRefGoogle Scholar
  11. 11.
    Huncharek M, Muscat J, Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer. 2009;61(1):47–69.CrossRefGoogle Scholar
  12. 12.
    Pöschl G, Stickel F, Wang XD, et al. Alcohol and cancer: genetic and nutritional aspects. Proc Nutr Soc. 2004;63(1):65–71.CrossRefGoogle Scholar
  13. 13.
    Lamarche F, Gonthier B, Signorini N, et al. Impact of ethanol and acetaldehyde on DNA and cell viability of cultured neurones. Cell Biol Toxicol. 2004;20(6):361–74.CrossRefGoogle Scholar
  14. 14.
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefGoogle Scholar
  15. 15.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486–97.CrossRefGoogle Scholar
  16. 16.
    Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome–a new worldwide definition. Lancet. 2005;366(9491):1059–62.CrossRefGoogle Scholar
  17. 17.
    Matsuzawa Y. Committee to evaluate diagnostic standards for metabolic syndrome: definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi. 2005;94:794–809. (in Japanese).CrossRefGoogle Scholar
  18. 18.
    Esposito K, Chiodini P, Colao A, et al. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012;35(11):2402–11.CrossRefGoogle Scholar
  19. 19.
    Jinjuvadia R, Lohia P, Jinjuvadia C, et al. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol. 2013;47(1):33–44.CrossRefGoogle Scholar
  20. 20.
    Esposito K, Chiodini P, Capuano A, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine. 2013;44(3):634–47.CrossRefGoogle Scholar
  21. 21.
    Morita T, Tabata S, Mineshita M, et al. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the self-defense forces health study. Asian Pac J Cancer Prev. 2005;6(4):485–9.PubMedGoogle Scholar
  22. 22.
    Kim JH, Lim YJ, Kim YH, et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomark Prev. 2007;16:1543–6.CrossRefGoogle Scholar
  23. 23.
    Guraya SY. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review. World J Gastroenterol. 2015;21(19):6026–31.CrossRefGoogle Scholar
  24. 24.
    Luo S, Li JY, Zhao LN, Yu T, et al. Diabetes mellitus increases the risk of colorectal neoplasia: an updated meta-analysis. Clin Res Hepatol Gastroenterol. 2016;40(1):110–23.CrossRefGoogle Scholar
  25. 25.
    Shi J, Xiong L, Li J, Cao H, et al. A linear dose-response relationship between fasting plasma glucose and colorectal cancer risk: systematic review and meta-analysis. Sci Rep. 2015;5:17591.CrossRefGoogle Scholar
  26. 26.
    Huang Y, Cai X, Qiu M, et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia. 2014;57(11):2261–9.CrossRefGoogle Scholar
  27. 27.
    Dong Y, Zhou J, Zhu Y, et al. Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies. Biosci Rep. 2017;37(6):BSR201745. (in press).CrossRefGoogle Scholar
  28. 28.
    Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One. 2013;8(1):e53916.CrossRefGoogle Scholar
  29. 29.
    Wang J, Yang DL, Chen ZZ, et al. Associations of body mass index with cancer incidence among populations, genders, and menopausal status: a systematic review and meta-analysis. Cancer Epidemiol. 2016;42:1–8.CrossRefGoogle Scholar
  30. 30.
    Passarelli MN, Newcomb PA. Blood lipid concentrations and colorectal adenomas: a systematic review and meta-analysis of colonoscopy studies in Asia, 2000-2014. Am J Epidemiol. 2016;183(8):691–700.CrossRefGoogle Scholar
  31. 31.
    Tian Y, Wang K, Li J, et al. The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis. Public Health Nutr. 2015;18(18):3355–70.CrossRefGoogle Scholar
  32. 32.
    Yao X, Tian Z. Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies. Cancer Causes Control. 2015;26(2):257–68.CrossRefGoogle Scholar
  33. 33.
    Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer. 2012;12(3):159–69.CrossRefGoogle Scholar
  34. 34.
    Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab. 2006;17:328–36.CrossRefGoogle Scholar
  35. 35.
    Kim S, Keku TO, Martin C, et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res. 2008;68(1):323–8.CrossRefGoogle Scholar
  36. 36.
    Neurath MF, Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 2011;22(2):83–9.CrossRefGoogle Scholar
  37. 37.
    Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9(5):361–71.CrossRefGoogle Scholar
  38. 38.
    Othman EM, Leyh A, Stopper H. Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro. Mutat Res. 2013;745–746:34–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Tetsuji Takayama
    • 1
    Email author
  • Yasushi Sato
    • 2
  • Naoki Muguruma
    • 1
  1. 1.Department of Gastroenterology and OncologyInstitutes of Biomedical Sciences, Tokushima University Graduate SchoolTokushimaJapan
  2. 2.Department of Community Medicine for Gastroenterology and OncologyInstitutes of Biomedical Sciences, Tokushima University Graduate SchoolTokushimaJapan

Personalised recommendations